Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer
Molecular cancer, 2017•Springer
Abstract Background Both mTOR and Skp2 play critical roles in gastric cancer (GC)
tumorigenesis. However, potential mechanisms for the association between these two
proteins remains unidentified. Methods The regulatory role for mTORC1 in Skp2 stability
was tested using ubiquitination assay. The functions of p-Skp2 (phosphorylation of Skp2)
were studied in vitro and in vivo. Expression of p-Skp2 and p-mTOR (phosphorylation of
mTOR) were shown in GC lines and in 169 human primary GC tissues. Results mTORC1 …
tumorigenesis. However, potential mechanisms for the association between these two
proteins remains unidentified. Methods The regulatory role for mTORC1 in Skp2 stability
was tested using ubiquitination assay. The functions of p-Skp2 (phosphorylation of Skp2)
were studied in vitro and in vivo. Expression of p-Skp2 and p-mTOR (phosphorylation of
mTOR) were shown in GC lines and in 169 human primary GC tissues. Results mTORC1 …
Background
Both mTOR and Skp2 play critical roles in gastric cancer (GC) tumorigenesis. However, potential mechanisms for the association between these two proteins remains unidentified.
Methods
The regulatory role for mTORC1 in Skp2 stability was tested using ubiquitination assay. The functions of p-Skp2 (phosphorylation of Skp2) were studied in vitro and in vivo. Expression of p-Skp2 and p-mTOR (phosphorylation of mTOR) were shown in GC lines and in 169 human primary GC tissues.
Results
mTORC1 can directly interact with Skp2 and phosphorylated Skp2 at Ser64, which sequentially protect Skp2 from ubiquitination and degradation. Furthermore, the phospho-deficient p-Skp2 (S64) mutant significantly suppresses GC cell proliferation and tumorigenesis. The expression of p-Skp2 was associated with p-mTOR in GC cell lines and tissues. Interestingly, the combination of p-Skp2 and p-mTOR was a better predictor of survival than either factor alone.
Conclusion
The mTORC1 function to regulate Skp2 by Ser64 phosphorylation may represent an oncogenic event in GC tumorigenesis. Moreover, our study also indicates that Skp2 Ser64 expression is a potential indicator in the treatment of GC patients using mTORC1 inhibitor.
Springer
